Diamyd Medical: Diamyd US Phase III Study Well Under Way

Posted by admin on March 11th, 2010 in Diabetes

Diamyd Medical (STO:DIAMB)(Pink Sheets:DMYDY) announces today that one hundred study participants have been included in the ongoing US Phase III study, DiaPrevent. The global Phase III program with the company’s lead drug candidate Diamyd® has thereby enrolled more than 430 children newly diagnosed with type 1 diabetes in Europe and the USA…

Leave a Reply

You must be logged in to post a comment.

« »